RLMD
NASDAQ · Pharmaceuticals
Relmada Therapeutics Inc
$4.23
+0.07 (+1.68%)
EPS Surprise History
Earnings Summary
Beats (Last 2)
0/2
Avg Surprise
-56.8%
Latest EPS
$-0.22
History
2 quarters
Earnings History
| Date | Quarter | EPS Est | EPS Actual | Surprise | Surprise % | Result |
|---|---|---|---|---|---|---|
| Aug 6, 2026 | Q3 FY2026 | $-0.20 | — | — | — | — |
| May 12, 2026 | Q2 FY2026 | $-0.20 | $-0.22 | -$0.02 | -10.6% | Miss |
| Mar 19, 2026 | Q1 FY2026 | $-0.14 | $-0.29 | -$0.15 | -103.1% | Miss |